| Sticking to the knitting: CIHR, innovation and Canadian biotech. | |
| | |
MedLine Citation:
|
PMID: 16078405 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The novel proposal outlined by Glenn Brimacombe suggests that the federal government directly participate in funding incremental venture capital investment in Canadian biotechnology, with the goal of facilitating commercialization of Canadian biotechnology and health sciences intellectual property. In this way, they suggest, the economic development benefits of the Canadian current investment in health sciences will be increased. The proposal is based on two premises that need further evaluation: (1) the biotechnology sector in Canada presently underperforms in terms of value creation; (2) this underperformance is due to inadequate venture capital investment. It is the author's view that, although several measures do suggest relative system underperformance, this is likely due to structural differences rather than inadequate venture capital investment. The absence of large, integrated, global biopharmaceutical firms based in Canada, the large number of very small biotech firms and the absence of a clear federal policy mandate supporting technology transfer and underinvestment in public sector funded basic research may all be contributory factors. Given the Canadian biotech sector's current efficiency at creating value from limited public investment in basic science, increasing the core CIHR budget might be an even better investment opportunity for limited incremental funding. |
| | |
Authors:
|
Jeff Edelson |
Related Documents
:
|
18634625 - Public-private partnerships in the health sector: the danish experience. 15318575 - Competition: an antidote to the high price of prescription drugs. 10127775 - Elasticity estimates from a dynamic model of interrelated demands for private and publi... 19696135 - 'a potential fifth column': conflicts and struggles for control in the context of local... 11218355 - Alcopops in sweden--a supply side initiative. 20107345 - Medical education for a healthier population: reflections on the flexner report from a ... |
Publication Detail:
|
Type: Comment; Journal Article |
Journal Detail:
|
Title: Healthcare quarterly (Toronto, Ont.) Volume: 8 ISSN: 1710-2774 ISO Abbreviation: - Publication Date: 2005 |
Date Detail:
|
Created Date: 2005-08-04 Completed Date: 2005-08-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101208192 Medline TA: Healthc Q Country: Canada |
Other Details:
|
Languages: eng Pagination: 65-8 Citation Subset: H |
Affiliation:
|
Johnson & Johnson Pharmaceutical Research and Development. jedelson@prdus.jnj.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biotechnology
/
economics* Canada Capital Financing Diffusion of Innovation* Financing, Government Humans Intellectual Property National Health Programs* |
| Comments/Corrections | |
Comment On:
|
Healthc Q. 2005;8(3):61-5, 2
[PMID:
16078404
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Health, healthcare and nation-building: a three-dimensional approach to innovation in Canada.
Next Document: Fraser Health PACS project: learning from experience in planning.